Ireland-France Bilateral Trade Analysis 2023
Complete trade statistics: $18.16B total volume •Ireland surplus: $2.70B
Ireland → France
$10.43B
Exports (2023)
France → Ireland
$7.73B
Imports (2023)
Trade Balance
$2.70B
Surplus for Ireland
Total Trade
$18.16B
Combined Volume
Trade Flow Visualization
Direct trade relationship between Ireland and France. Green line shows exports from Ireland, red line shows imports.
Detailed Product Trade Analysis
Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the Ireland-France commercial relationship and competitive positioning in global markets.
Ireland → France Exports
Export Market Intelligence
🎯 Strategic Export Focus
Ireland's export portfolio to France demonstrates strong diversification across multiple sectors, with medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale representing a key competitive advantage in this bilateral market.
France → Ireland Imports
Import Dependency Profile
📦 Import Strategy Analysis
Ireland's import pattern from France reveals strategic sourcingin heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn), highlighting complementary economic structures and potential supply chain optimization opportunities.
Competitive Trade Position Analysis
Market Leadership
Ireland demonstrates competitive strength in exportingmedicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale to France, leveraging comparative advantages.
Trade Complementarity
The bilateral relationship showsstrongcomplementarity, with each country specializing in different sectors.
Growth Potential
The $18.16B trade volume indicates substantial economic integration with room for expansion in emerging sectors.
Executive Summary: Ireland-France Trade Relationship
Key Trade Highlights 2023
- Total Trade Volume: $18.16 billionrepresenting a significant bilateral economic relationship
- Trade Balance: Ireland maintains a surplus of $2.70 billion
- Export Focus: Ireland's primary exports include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale, telephones for cellular networks or for other wireless networks
- Import Dependencies: Key imports from France include heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn), aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg, heterocyclic compounds: n.e.c. in headings no. 2933
Strategic Trade Indicators
📈 Market Position: This bilateral trade relationship represents a significant global trade partnerships, with complementary economic strengths driving sustained commercial exchange.
Historical Trade Analysis & Economic Context
Trade Evolution Timeline
2019-2023: Recent Trends
Current trade volume of $18.16B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.
2015-2019: Growth Period
Sustained expansion in bilateral trade driven by complementary economic structures, with Ireland leveraging its comparative advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.
2010-2015: Foundation Building
Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.
Pre-2010: Early Development
Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.
Key Economic Drivers
Comparative Advantage
Ireland's specialization in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail salecomplements France's demand patterns, creating natural trade synergies.
Supply Chain Integration
Deep integration in global value chains has strengthened bilateral linkages, particularly in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn).
Market Access & Trade Policy
Favorable trade agreements and market access conditions have facilitated the growth of this $18.16B bilateral relationship.
Trade Pattern Insights
Trade Relationship Outlook
The $18.16B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.
Economic Impact & Strategic Outlook
Economic Impact Assessment
Trade Volume Impact
The $18.16 billion bilateral trade volume represents a significant economic factorfor both economies.
Industrial Integration
Trade flows in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale and heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn) demonstrate deep industrial linkages and supply chain integration.
Trade Balance Effects
Ireland's trade surplus of $2.70 billion strengthens its overall economic position in this bilateral relationship.
Strategic Future Outlook
🚀Growth Opportunities
⚠️Risk Factors
🎯Strategic Recommendations
- Strengthen cooperation in high-value sectors beyond current trade patterns
- Develop alternative supply chains to reduce dependency risks
- Explore joint ventures in emerging technology sectors
- Enhance trade facilitation and reduce transaction costs
Market Position & Competitive Summary
The bilateral trade relationship between Ireland and France represents a total trade volume of $18.16 billion in 2023. This partnership demonstrates a favorable trade balance for Ireland, with exports exceeding importsby $2.70 billion.
Export Strengths
Ireland's exports to France total $10.43 billion, with competitive advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, representing $1.40B or13.4% of bilateral exports.
Import Dependencies
Imports from France amount to $7.73 billion, highlighting economic interdependence in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn), with Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (INN) and methyprylon (INN) comprising27.8% of total imports.
The trade relationship reflects broader economic patterns and comparative advantages. The trade surplus indicates Ireland's competitive position in this bilateral relationship. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.
Download Bilateral Trade Data
Access detailed trade data between Ireland and France in multiple formats.
Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) • Last Updated: January 2025 • Coverage: 1995-2023